Biomarker solutions

1. biomarker solutions 1.1.1
your projects,
your needs
discovery preclinical R&D clinical trials
target discovery animal model validation clinical entry selection
target validation predictive toxicity dose selection
drug candidate validation drug efficacy testing patient stratification
signalling pathways clinical candidate selection patient monitoring
drug delivery pathways translation to humans mode of action
biomarker
solutions
protein biomarker expertise proof-of-mechanism
fully customised models & services drug portfolio management
consulting & technical support personalised medicine
biomarker
services
pharmacodynamics in vitro & ex vivo assays
biomarker selection toxicity, tolerability cell & tissue imaging project
function & efficacy human & animal models
& assay development & safety testing image analysis management
assessment tissues & cell culture
organs, systems, cells... pathologies
gastrointestinal tract cancer
cardiovascular system inflammatory diseases
central nervous systems service portfolio metabolic diseases
lungs, skin... respiratory diseases
membrane, nucleus cardiovascular diseases
endosomes, Golgi... CNS diseases...
IHC, histology laser confocal biomarker analysis morphometry
specimen ELISA flow
cell culture miscroscopy detection & expression & morphology
collection cytometry
cell biology videomicroscopy localisation & quantification analysis
your benefits
better, faster, cheaper
improved pipeline quality • better R&D portfolios • decreased cycle times • improved cost effectiveness
tel: +33 491 10 60 87 • email: info@biovays.com • biovays.com

2. biomarker solutions > 1.1.1
biomarker solutions
automated protein biomarker analysis
optimisation of resources & improved cost-effectiveness
accelerating clinical development
timely, specific, relevant, high quality data
cost-cutting drug portfolio management: improved clinical trial success rates
better R&D portfolios & improved pipeline quality
solutions for drug protein biomarkers
success effective & reliable indicators of disease states and drug efficacy
unique & specific: target/mechanism/disease/outcome-specific
early indicators of success/failure: earlier than clinical endpoints
more discriminating tests of product safety & efficacy
novel strategies & new technologies effective patient stratification
effective trial design & early decision-making
for fast track process development
As a biomarker solutions provider, biomarker services
Biovays offers you specialist knowledge, biomarker expertise & consulting
innovative approaches and cost-effective
project management & technical support
alternatives for your research
tailor-made protocols & customised models
and development projects.
From target discovery through to FDA biomarker selection & assay development
approval, biomarker analysis streamlines pharmacodynamics, function & efficacy testing
drug development, reduces costs and toxicity analysis: safety & tolerability assessment
boosts drug approval success rates. in vitro & ex vivo assays
microscopic digital biological imaging
qualitative & quantitative image analysis
biomarker analysis: detection, localisation, quantification
morphometric & morphologic analysis
portfolio of services
colocalisation analysis
GPCR internalisation
protein translocation
surface protein expression (receptors...)
protein-protein interaction analysis
structure analysis (folding)
analysis of cell functions (migration, differentiation, proliferation...)
protein & cell growth assays (dynamic growth processes)
cell tracking & cellular trafficking
drug delivery pathways
signalling pathways
transcription factor activation
enzyme activity analysis
ATP quantification
cell toxicity, proliferation, viability measurement
quantification of cytokines, nucleic acids...
apoptosis & cell adhesion assays
analysis of molecular interactions
tel: +33 491 10 60 87 • email: info@biovays.com • biovays.com